- Joined
- Nov 19, 2023
- Messages
- 301
As a push to try and centralize information on various novel psych0@chive substances (NPS) into this particular section of the forum (as opposed to on vendor threads, or in non-RC sections), I thought it would be fitting to open up discussion around a new NPS making the rounds - DMNPC (N,O-Dimethyl-4β-(2-naphthyl)piperidine-3β-carboxylate).
A potent dopamine reuptake inhibitor (2.5x that of c0c@ine), that’s highly selective towards DAT and NET. Even more interestingly, it’s the most selective towards 5HTT. However this one is so new that it’s lacking even experience reports on boards like r3dd1t and BL.
A few popular vendors just started stocking this one recently. It seems as though it’s got the potential to be a hit given the limited scientific research that is out there on it.
Has anyone taken the plunge with this one yet? If so, how was it? Things like dosages, time of onset/duration/offset, primary effects and side effects would be extremely useful!
Stay safe and thank you ahead of time for your contribution.
-Mb
A potent dopamine reuptake inhibitor (2.5x that of c0c@ine), that’s highly selective towards DAT and NET. Even more interestingly, it’s the most selective towards 5HTT. However this one is so new that it’s lacking even experience reports on boards like r3dd1t and BL.
A few popular vendors just started stocking this one recently. It seems as though it’s got the potential to be a hit given the limited scientific research that is out there on it.
Has anyone taken the plunge with this one yet? If so, how was it? Things like dosages, time of onset/duration/offset, primary effects and side effects would be extremely useful!
Stay safe and thank you ahead of time for your contribution.
-Mb